Loading…
MAGNESIUM SULFATE is a brand name for Magnesium Sulfate, supplied as a solution. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: , 1.1 Pediatrics 07/2025
Verbatim from this product's HC label. Tap a section to expand.
3 Pediatrics 07/2025 TABLE OF CONTENTS Certain sections or subsections that are not applicable at the time of the preparation of the most recent authorized product monograph are not listed RECENT MAJOR LABEL CHANGES ..........................................................................................
2 TABLE OF CONTENTS ............................................................................................................ 2 PART I: HEALTH PROFESSIONAL INFORMATION ....................................................................
4 1 INDICATIONS ............................................................................................................. 1 Pediatrics................................................................................................................
2 Geriatrics ................................................................................................................ 4 2 CONTRAINDICATIONS ................................................................................................
4 4 DOSAGE AND ADMINISTRATION................................................................................ 1 Dosing Considerations ........................................................................................... 2 Recommended Dose and Dosage Adjustment ......................................................
3 Dilution Prior to Administration ............................................................................ 5 5 OVERDOSAGE............................................................................................................
5
1 Adverse Reaction Overview Principal adverse reactions are related to the high plasma levels of magnesium and include flushing, sweating, hypotension, circulatory collapse, and cardiac and central nervous system depression. Respiratory depression is the most life-threatening effect.
Hypocalcemia with signs of tetany secondary to magnesium sulfate therapy for eclampsia has been reported.
3 Pediatrics 07/2025 TABLE OF CONTENTS Certain sections or subsections that are not applicable at the time of the preparation of the most recent authorized product monograph are not listed RECENT MAJOR LABEL CHANGES ..........................................................................................
2 TABLE OF CONTENTS ............................................................................................................ 2 PART I: HEALTH PROFESSIONAL INFORMATION ....................................................................
4 1 INDICATIONS ............................................................................................................. 1 Pediatrics................................................................................................................
2 Geriatrics ................................................................................................................ 4 2 CONTRAINDICATIONS ................................................................................................
4 4 DOSAGE AND ADMINISTRATION................................................................................ 1 Dosing Considerations ........................................................................................... 2 Recommended Dose and Dosage Adjustment ......................................................
3 Dilution Prior to Administration ............................................................................ 5 5 OVERDOSAGE............................................................................................................
5 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING ................................ 6 7 WARNINGS AND PRECAUTIONS ................................................................................. 1 Special Population..................................................................................................
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Magnesium Sulfate in Canada.
Know a brand we are missing in Canada? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
1 Pregnant Women ............................................................................................... 2 Breast-feeding .................................................................................................... 3 Pediatrics............................................................................................................
4 Geriatrics ............................................................................................................ 8 8 ADVERSE REACTIONS.................................................................................................
1 Adverse Reaction Overview ................................................................................... 9 9 DRUG INTERACTIONS ................................................................................................ 4 Drug-Drug Interactions ..........................................................................................
5 Drug-Food Interactions .......................................................................................... 6 Drug-Herb Interactions .......................................................................................... 7 Drug-Laboratory Test Interactions.........................................................................
9 10 CLINICAL PHARMACOLOGY ........................................................................................ 1 Mechanism of Action ............................................................................................. 3 Pharmacokinetics .................................................................................................
10 11 STORAGE, STABILITY AND DISPOSAL ........................................................................ 10 12 SPECIAL HANDLING INSTRUCTIONS.......................................................................... 10 PART II: SCIENTIFIC INFORMATION .....................................................................................
11 13 PHARMACEUTICAL INFORMATION .......................................................................... 11 14 CLINICAL TRIALS ......................................................................................................
11 15 MICROBIOLOGY ...................................................................................................... 11 16 NON-CLINICAL TOXICOLOGY ....................................................................................
11 17 SUPPORTING PRODUCT MONOGRAPHS ................................................................... 11 PATIENT MEDICATION INFORMATION ................................................................................ 3% may be of therapeutic value in the following conditions: • as an anticonvulsant for preeclampsia and eclampsia of pregnancy; • as an electrolyte replenisher for hypomagnesemia and magnesium deficiency to maintain normal neuromuscular irritability.
1 Pediatrics Pediatrics (<18 years of age): Health Canada has not authorized an indication for pediatric use. 3 Pediatrics). 2 Geriatrics Geriatrics: Health Canada has not authorized an indication for geriatric use. 3% should not be administered […]